FIGS, Inc. $FIGS Shares Bought by Sei Investments Co.

Sei Investments Co. boosted its holdings in shares of FIGS, Inc. (NYSE:FIGS) by 148.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 148,262 shares of the company’s stock after buying an additional 88,468 shares during the quarter. Sei Investments Co.’s holdings in FIGS were worth $2,190,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in FIGS by 4.4% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 77,219 shares of the company’s stock worth $354,000 after purchasing an additional 3,276 shares in the last quarter. Woodline Partners LP purchased a new position in shares of FIGS during the 1st quarter valued at approximately $3,199,000. Creative Planning lifted its stake in shares of FIGS by 181.3% in the 2nd quarter. Creative Planning now owns 65,740 shares of the company’s stock valued at $371,000 after purchasing an additional 42,367 shares during the period. Prudential Financial Inc. acquired a new position in shares of FIGS in the 2nd quarter valued at $70,000. Finally, Russell Investments Group Ltd. boosted its holdings in FIGS by 102.4% during the second quarter. Russell Investments Group Ltd. now owns 147,440 shares of the company’s stock worth $832,000 after buying an additional 74,578 shares in the last quarter. 92.21% of the stock is currently owned by institutional investors and hedge funds.

FIGS Price Performance

Shares of FIGS stock opened at $14.21 on Friday. The stock’s 50 day simple moving average is $10.92 and its 200-day simple moving average is $12.50. The stock has a market cap of $2.37 billion, a P/E ratio of 43.06 and a beta of 1.03. FIGS, Inc. has a 1-year low of $6.07 and a 1-year high of $17.48.

FIGS (NYSE:FIGS) last announced its quarterly earnings data on Thursday, May 7th. The company reported $0.03 EPS for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02. The firm had revenue of $159.90 million for the quarter, compared to the consensus estimate of $153.15 million. FIGS had a return on equity of 12.65% and a net margin of 8.72%.The business’s revenue was up 28.0% on a year-over-year basis. As a group, research analysts expect that FIGS, Inc. will post 0.27 EPS for the current fiscal year.

Trending Headlines about FIGS

Here are the key news stories impacting FIGS this week:

• Positive Sentiment: Quarterly results exceeded expectations. FIGS reported second-quarter revenue of approximately $196.6 million, up 28.8% year over year and ahead of the $186.2 million consensus estimate. Adjusted earnings were reported at $0.15 per share versus analyst expectations of $0.07 and $0.04 in the prior-year quarter. FIGS Releases Second Quarter 2026 Financial Results
• Positive Sentiment: Management raised its full-year outlook. FIGS issued 2026 revenue guidance of approximately $757.3 million, above the $729.1 million Wall Street consensus. The improved outlook signals continued demand for its healthcare apparel and supports expectations for faster growth. Figs shares jump after strong second-quarter results and higher 2026 outlook
• Positive Sentiment: Share repurchases added another support. FIGS increased its buyback authorization, potentially enhancing per-share earnings and signaling management confidence in the company’s valuation and cash-generation outlook. Figs rallies on impressive growth, upbeat outlook, and increased buyback
• Positive Sentiment: BTIG became more bullish. BTIG Research raised its price target from $20 to $22 and reiterated a “buy” rating, reflecting increased confidence in FIGS’ growth trajectory. Benzinga analyst note
• Neutral Sentiment: Analyst opinion remains mixed. Telsey Advisory Group lowered its target from $17 to $16 and kept a “market perform” rating, suggesting the recent rally may have already priced in much of the earnings improvement. The Fly analyst note

Analyst Ratings Changes

Several research firms have recently issued reports on FIGS. Barclays increased their target price on shares of FIGS from $17.00 to $20.00 and gave the stock an “overweight” rating in a research note on Friday. BTIG Research boosted their price objective on FIGS from $20.00 to $22.00 and gave the company a “buy” rating in a research report on Friday. Zacks Research downgraded FIGS from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 8th. Telsey Advisory Group dropped their price target on shares of FIGS from $17.00 to $16.00 and set a “market perform” rating on the stock in a research note on Friday. Finally, Morgan Stanley boosted their price target on shares of FIGS from $8.00 to $15.00 and gave the stock an “equal weight” rating in a report on Monday, April 13th. Six research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat, FIGS presently has an average rating of “Moderate Buy” and an average price target of $18.71.

FIGS Profile

FIGS, Inc operates as a direct-to-consumer designer and retailer of medical apparel and accessories. The company offers a range of products tailored to the needs of healthcare professionals, including scrub sets, lab coats, tops, bottoms, outerwear, footwear, and performance fabrics designed for comfort, durability, and antimicrobial protection. Through its e-commerce platform and a growing network of retail stores, FIGS provides customizable uniforms and accessories with a focus on innovative materials and functional design features such as four-way stretch fabrics, moisture-wicking technology, and multiple secure pockets.

Founded in 2013 by Heather Hasson and Trina Spear, FIGS set out to disrupt the traditional medical uniform market by emphasizing both form and function.